Buscar
Mostrando ítems 1-10 de 70
Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimonyResposta terapêutica bem sucedida de casos resistentes de leishmaniose mucocutânea a doses muito baixas de antimônio
(Sociedade Brasileira de Medicina Tropical - SBMT, 2023)
Comparative efficacies of two antimony regimens to treat Leishmania braziliensis-induced cutaneous Leishmaniasis in rhesus macaques (Macaca mulatta)
(American Society for Microbiology, 2017)
High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 2020)
Efficacy of Meglumine Antimoniate in a Low Polymerization State Orally Administered in a Murine Model of Visceral Leishmaniasis
(American Society for Microbiology, 2019)
Successful therapeutic response of resistant cases of mucocutaneous leishmaniasis to a very low dose of antimony
(Sociedade Brasileira de Medicina Tropical - SBMT, 2006)
São relatados dois casos de leishmaniose mucocutânea resistentes ao tratamento. Depois das terapêuticas iniciais (antimônio, anfotericina B e/ou pentamidina), os pacientes receberam um esquema alternativo: uma ampola de ...
High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients
(Fundação Oswaldo Cruz. Instituto Oswaldo Cruz., 1996)